Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial

Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial

Abstract Background Lithium is the gold-standard treatment for bipolar disorder, is highly effective in treating major depressive disorder, and has anti-suicidal properties. However, clinicians are increasingly avoiding lithium largely due to fears of renal toxicity. Nephrogenic Diabetes Insipidus (...

Full description

Bibliographic Details
Main Authors: Jocelyn Fotso Soh, Susana G. Torres-Platas, Serge Beaulieu, Outi Mantere, Robert Platt, Istvan Mucsi, Sybille Saury, Suzane Renaud, Andrea Levinson, Ana C. Andreazza, Benoit H. Mulsant, Daniel Müller, Ayal Schaffer, Annemiek Dols, Pablo Cervantes, Nancy CP Low, Nathan Herrmann, Birgitte M. Christensen, Francesco Trepiccione, Tarek Rajji, Soham Rej
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Psychiatry
Subjects:
Lithium
Nephrogenic diabetes insipidus
Kidney function
Atorvastatin
Placebo
Urinary osmolality
Online Access:http://link.springer.com/article/10.1186/s12888-018-1793-9

Internet

http://link.springer.com/article/10.1186/s12888-018-1793-9

Similar Items